Duloxetine Capsule, Delayed Release
Product Images NDC 76420-623

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 76420-623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg (Duloxetine 20mg)

FDA Label Image

30mg (Duloxetine 30mg)

FDA Label Image

40mg (Duloxetine 40mg)

FDA Label Image

60mg (Duloxetine 60mg)

Not available.*

FDA Label Image

Figure1 (Duloxetine Fig1)

FDA Label Image

Figure10 (Duloxetine Fig10)

This text appears to be a description related to the medication "Duloxetine" used as a placebo. The suggested dosage is either 60 mg or 120 mg once daily. The remaining text is not readable, therefore unable to provide further information.*

FDA Label Image

Figure2 (Duloxetine Fig2)

This text provides information about the proportion of patients experiencing relapse over time in a treatment study. The graph shows the proportion of patients with relapse plotted against time from randomization to relapse, measured in days. The treatment options included a placebo and a medication called duloxetine. The graph shows data points at various time intervals, ranging from 0 to 300 days.*

FDA Label Image

Figure3 (Duloxetine Fig3)

FDA Label Image

Figure4 (Duloxetine Fig4)

FDA Label Image

Figure5 (Duloxetine Fig5)

FDA Label Image

Figure6 (Duloxetine Fig6)

FDA Label Image

Figure7 (Duloxetine Fig7)

FDA Label Image

Figure8 (Duloxetine Fig8)

FDA Label Image

Figure9 (Duloxetine Fig9)

FDA Label Image

Structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.